Cargando…
The need for a correct oxygen-ozone autohemotherapy (O(3)-AHT) in patients with mild to moderate COVID-19 pneumonia
Autores principales: | Chirumbolo, Salvatore, Pandolfi, Sergio, Valdenassi, Luigi, Bertossi, Dario, Franzini, Marianno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782567/ https://www.ncbi.nlm.nih.gov/pubmed/33400161 http://dx.doi.org/10.1007/s11739-020-02592-w |
Ejemplares similares
-
Male vs. Female Differences in Responding to Oxygen–Ozone Autohemotherapy (O(2)-O(3)-AHT) in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Chirumbolo, Salvatore, et al.
Publicado: (2021) -
Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy
por: Tirelli, Umberto, et al.
Publicado: (2021) -
Insights on the mechanisms of action of ozone in the medical therapy against COVID-19
por: Chirumbolo, Salvatore, et al.
Publicado: (2021) -
Oxygen-ozone (O(2)-O(3)) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported
por: Franzini, Marianno, et al.
Publicado: (2020) -
Ozone adjunct treatment in facing multidrug‐resistant bacteria?
por: Chirumbolo, Salvatore, et al.
Publicado: (2023)